These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 18976075)
1. Characterization of a side population of astrocytoma cells in response to temozolomide. Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075 [TBL] [Abstract][Full Text] [Related]
2. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Bleau AM; Hambardzumyan D; Ozawa T; Fomchenko EI; Huse JT; Brennan CW; Holland EC Cell Stem Cell; 2009 Mar; 4(3):226-35. PubMed ID: 19265662 [TBL] [Abstract][Full Text] [Related]
3. The side story of stem-like glioma cells. Persson AI; Weiss WA Cell Stem Cell; 2009 Mar; 4(3):191-2. PubMed ID: 19265652 [TBL] [Abstract][Full Text] [Related]
4. Distinct population of hair cell progenitors can be isolated from the postnatal mouse cochlea using side population analysis. Savary E; Hugnot JP; Chassigneux Y; Travo C; Duperray C; Van De Water T; Zine A Stem Cells; 2007 Feb; 25(2):332-9. PubMed ID: 17038670 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide. Chai KM; Wang CY; Liaw HJ; Fang KM; Yang CS; Tzeng SF Oncotarget; 2014 Nov; 5(21):10901-15. PubMed ID: 25337721 [TBL] [Abstract][Full Text] [Related]
6. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation. Yu G; Wu F; Wang E Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells. Wang Q; Qian J; Wang J; Luo C; Chen J; Hu G; Lu Y J Neurooncol; 2013 Mar; 112(1):73-82. PubMed ID: 23292182 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study. Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131 [TBL] [Abstract][Full Text] [Related]
9. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536 [TBL] [Abstract][Full Text] [Related]
10. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine. Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672 [TBL] [Abstract][Full Text] [Related]
11. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3]. Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115 [TBL] [Abstract][Full Text] [Related]
12. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer. Xie ZY; Lv K; Xiong Y; Guo WH Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584 [TBL] [Abstract][Full Text] [Related]
13. Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment. Trog D; Moenkemann H; Haertel N; Schüller H; Golubnitschaja O Amino Acids; 2005 Mar; 28(2):213-9. PubMed ID: 15723240 [TBL] [Abstract][Full Text] [Related]
14. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway. Han S; Li Z; Master LM; Master ZW; Wu A Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489 [TBL] [Abstract][Full Text] [Related]
15. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis. Friedman HS Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348 [TBL] [Abstract][Full Text] [Related]
16. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Wang J; Sai K; Chen FR; Chen ZP Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289 [TBL] [Abstract][Full Text] [Related]
17. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma. Huang S; Qi P; Zhang T; Li F; He X Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180 [TBL] [Abstract][Full Text] [Related]
18. Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. Munoz JL; Rodriguez-Cruz V; Ramkissoon SH; Ligon KL; Greco SJ; Rameshwar P Oncotarget; 2015 Jan; 6(2):1190-201. PubMed ID: 25595896 [TBL] [Abstract][Full Text] [Related]
19. Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2. de Gooijer MC; de Vries NA; Buckle T; Buil LCM; Beijnen JH; Boogerd W; van Tellingen O Neoplasia; 2018 Jul; 20(7):710-720. PubMed ID: 29852323 [TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of cancer stem cells from medulloblastoma. Liu J; Chi N; Zhang JY; Zhu W; Bian YS; Chen HG Genet Mol Res; 2015 Apr; 14(2):3355-61. PubMed ID: 25966102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]